154
Views
7
CrossRef citations to date
0
Altmetric
Retina

Utility of Removal of Vitreous Cortex Remnants during Vitrectomy for Primary Rhegmatogenous Retinal Detachment Repair

, , , , &
Pages 1444-1449 | Received 12 May 2022, Accepted 13 Jul 2022, Published online: 26 Jul 2022

References

  • Sodhi A, Leung L-S, Do DV, Gower EW, Schein OD, Handa JT. Recent trends in the management of rhegmatogenous retinal detachment. Surv Ophthalmol. 2008;53(1):50–67. doi:10.1016/j.survophthal.2007.10.007.
  • Starr MR, Obeid A, Ryan EH, Ryan C, Ammar M, Patel LG, Forbes NJ, Capone A, Emerson GG, Joseph DP, et al. Retinal detachment with inferior retinal breaks: primary vitrectomy versus vitrectomy with scleral buckle (PRO study report no. 9). Retina. 2021;41(3):525–530. doi:10.1097/iae.0000000000002917.
  • Ryan EH, Ryan CM, Forbes NJ, Yonekawa Y, Wagley S, Mittra RA, Parke DW, Joseph DP, Emerson GG, Shah GK, et al. Primary retinal detachment outcomes study report number 2 phakic retinal detachment outcomes. Ophthalmology. 2020;127(8):1077–1085. doi:10.1016/j.ophtha.2020.03.007.
  • Joseph DP, Ryan EH, Ryan CM, Forbes NJK, Wagley S, Yonekawa Y, Mittra RA, Parke DW, Emerson GG, Shah GK, et al. Primary retinal detachment outcomes study: pseudophakic retinal detachment outcomes primary retinal detachment outcomes study report number 3. Ophthalmology. 2020;127(11):1507–1514. doi:10.1016/j.ophtha.2020.05.005.
  • Heimann H, Bartz-Schmidt KU, Bornfeld N, Weiss C, Hilgers R-D, Foerster MH. Group SB versus PV in RRDS. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment a prospective randomized multicenter clinical study. Ophthalmology. 2007;114(12):2142–2154.e4. doi:10.1016/j.ophtha.2007.09.013.
  • Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res. 1998;17(1):77–98. doi:10.1016/s1350-9462(97)00007-4.
  • Pastor JC, de la Rúa ER, Martín F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 2002;21(1):127–144. doi:10.1016/S1350-9462(01)00023-4.
  • Idrees S, Sridhar J, Kuriyan AE. Proliferative vitreoretinopathy: a review. Int Ophthalmol Clin. 2019;59(1):221–240. doi:10.1097/iio.0000000000000258.
  • Girard P, Mimoun G, Karpouzas I, Montefiore G. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina. 1994;14(5):417–424. doi:10.1097/00006982-199414050-00005.
  • Asaria RHY, Kon CH, Bunce C, Charteris DG, Wong D, Luthert PJ, Khaw PT, Aylward GW. How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology. 2001;108(7):1184–1186. doi:10.1016/s0161-6420(01)00553-x.
  • Pastor JC. Proliferative vitreoretinopathy an overview. Surv Ophthalmol. 1998;43(1):3–18. doi:10.1016/S0039-6257(98)00023-X.
  • Esser P, Heimann K, Wiedemann P. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol. 1993;77(11):731–733. doi:10.1136/bjo.77.11.731.
  • Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol. 1989;107(8):1147–1151. doi:10.1001/archopht.1989.01070020213027.
  • Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol. 2008;246(3):329–332. doi:10.1007/s00417-007-0743-x.
  • Gupta P, Yee KMP, Garcia P, Rosen RB, Parikh J, Hageman GS, Sadun AA, Sebag J. Vitreoschisis in macular diseases. Br J Ophthalmol. 2011;95(3):376–380. doi:10.1136/bjo.2009.175109.
  • Sonoda K-H, Sakamoto T, Enaida H, Miyazaki M, Noda Y, Nakamura T, Ueno A, Yokoyama M, Kubota T, Ishibashi T. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology. 2004;111(2):226–230. doi:10.1016/j.ophtha.2003.05.034.
  • Kishi S, Demaria C, Shimizu K. Vitreous cortex remnants at the fovea after spontaneous vitreous detachment. Int Ophthalmol. 1986;9(4):253–260. doi:10.1007/bf00137539.
  • Sayanagi K, Ikuno Y, Tano Y. Reoperation for persistent myopic foveoschisis after primary vitrectomy. Am J Ophthalmol. 2006;141(2):414–417. doi:10.1016/j.ajo.2005.09.009.
  • Kato Y, Inoue M, Hirakata A. Effect of foveal vitreous cortex removal to prevent epiretinal membrane after vitrectomy for rhegmatogenous retinal detachment. Ophthalmol Retina. 2021;5(5):420–428. doi:10.1016/j.oret.2020.08.020.
  • Assi A, Khoueir Z. Prevalence of vitreous cortex remnants in eyes with primary rhegmatogenous retinal detachment undergoing vitrectomy. Retina. 2021;41(7):1403–1406. doi:10.1097/IAE.0000000000003056.
  • Lewis JM, Park I, Ohji M, Saito Y, Tano Y. Diamond-dusted Silicone cannula for epiretinal membrane separation during vitreous surgery. Am J Ophthalmol. 1997;124(4):552–554. doi:10.1016/s0002-9394(14)70874-8.
  • Govetto A, Lalane RA, Sarraf D, Figueroa MS, Hubschman JP. Insights into epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme. Am J Ophthalmol. 2017;175:99–113. doi:10.1016/j.ajo.2016.12.006.
  • Kimura H, Kuroda S, Nagata M. Premacular cortical vitreous in patients with a rhegmatogenous retinal detachment. Retina. 2004;24(2):329–330. doi:10.1097/00006982-200404000-00032.
  • Cho EH, Ku HC, Il W, Lee EK. Residual vitreous cortex at the fovea during vitrectomy for primary rhegmatogenous retinal detachment repair. Retina. 2018;38(8):1549–1555. doi:10.1097/iae.0000000000001734.
  • Overdam K. Vitreoschisis‐induced vitreous cortex remnants: missing link in proliferative vitreoretinopathy. Acta Ophthalmol. 2020;98(2):e261–e262. doi:10.1111/aos.14216.
  • Chen TY, Yang CM, Liu KR. Intravitreal triamcinolone staining observation of residual undetached cortical vitreous after posterior vitreous detachment. Eye. 2006;20(4):423–427. doi:10.1038/sj.eye.6701892.
  • Itakura H, Kishi S. Aging changes of vitreomacular interface. Retina. 2011;31(7):1400–1404. doi:10.1097/iae.0b013e318206cb43.
  • Kakehashi A, Schepens CL, A de S-N, Jalkh AE, Trempe CL. Biomicroscopic findings of posterior vitreoschisis. Ophthalmic Surg. 1993;24(12):846–850. doi:10.3928/1542-8877-19931201-10.
  • Grigoropoulos VG, Benson S, Bunce C, Charteris DG. Functional outcome and prognostic factors in 304 eyes managed by retinectomy. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):641–649. doi:10.1007/s00417-006-0479-z.
  • Federman JL, Eagle RC. Extensive peripheral retinectomy combined with posterior 360° retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases. Ophthalmology. 1990;97(10):1305–1320. doi:10.1016/S0161-6420(90)32416-8.
  • Han DP, Lewis MT, Kuhn EM, Abrams GW, Mieler WF, Williams GA, Aaberg TM. Relaxing retinotomies and retinectomies: surgical results and predictors of visual outcome. Arch Ophthalmol. 1990;108(5):694–697. doi:10.1001/archopht.1990.01070070080039.
  • Tseng JJ, Barile GR, Schiff WM, Akar Y, Vidne-Hay O, Chang S. Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy. Am J Ophthalmol. 2005;140(4):628.e1–628.e10. doi:10.1016/j.ajo.2005.04.021.
  • Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, Schwartz SD. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology. 2006;113(11):2041–2047. doi:10.1016/j.ophtha.2006.05.039.
  • de Silva DJ, Kwan A, Bunce C, Bainbridge J. Predicting visual outcome following retinectomy for retinal detachment. Br J Ophthalmol. 2008;92(7):954–958. doi:10.1136/bjo.2007.131540.
  • Banerjee PJ, Quartilho A, Bunce C, Xing W, Zvobgo TM, Harris N, Charteris DG. Slow-release dexamethasone in proliferative vitreoretinopathy: a prospective, randomized controlled clinical trial. Ophthalmology. 2017;124(6):757–767. doi:10.1016/j.ophtha.2017.01.021.
  • Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology. 2008;115(11):1938–1943. doi:10.1016/j.ophtha.2008.05.016.
  • Kuhn F, Mester V, Berta A. The tano diamond dusted membrane scraper, indications and contraindications. Acta Ophthalmol Scand. 1998;76(6):754–759. doi:10.1034/j.1600-0420.1998.760626.x.
  • Leung EH, Flynn HW, Rosenfeld PJ. Crescent-shaped retinal defects associated with membrane peeling with a diamond-dusted membrane scraper. Ophthalmic Surg Lasers Imaging Retina. 2016;47(1):90–93. doi:10.3928/23258160-20151214-16.
  • Hirakata A, Inoue M, Oshitari K, Okada AA, Nagamoto T, Tano Y. Histopathological examination of internal limiting membrane surface after scraping with diamond‐dusted membrane scraper. Acta Ophthalmol. 2010;88(7):e293–e294. doi:10.1111/j.1755-3768.2009.01730.x.
  • Sartini F, Menchini M, Loiudice P, Nardi M, Figus M, Casini G. Surgical technique for removing vitreous cortex remnants using a diamond‐dusted membrane scraper. Acta Ophthalmol. 2022;100(3):344–347. doi:10.1111/aos.14933.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.